Back

Lipoprotein A and the risk of developing left ventricle systolic dysfunction in the immediate post-acute coronary syndrome period.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 11 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Assistant Professor Ioana-Patricia Rodean

Emergency County Hospital of Targu Mures, Targu Mures (Romania)

5 More presentations in this session

Presentation thumbnail
Exploring bioelectrical phase angle as a biomarker in heart failure patients
Doctor B. Braganca (Porto, PT)
Abstract Slides Video
Presentation thumbnail
ID and high estimated plasma volume status in heart failure patients
Professor A. Safarova (Baku, AZ)
Abstract Slides Video
Presentation thumbnail
Non-invasive bioimpedance analysis predicts NT-proBNP changes during hospitalization in a cohort of acutely decompensated heart failure patients
Mr A. Herrmann (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
In-hospital bioimpedance-derived total body water predicts short-term cardiovascular mortality and re-hospitalizations in acute decompensated heart failure patients.
Doctor A. Faragli (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research
Doctor V. Kalantaryan (Yerevan, AM)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 11

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Impact of lipoprotein A on long-term outcomes in acute coronary syndrome: a retrospective cohort analysis
thumbnail
Congress Presentation
Lipoprotein(a) levels and LPA genotypes are not associated with echocardiographic measures of left ventricular structure and function in the general population
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute coronary syndrome: analysis of sex, age, and cardiovascular risk factors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources